Boceprevir Plus Peginterferon Alfa-2a/Ribavirin in Treatment-Naïve Hepatitis C Virus Genotype 1 Patients: International Phase IIIb/IV TriCo Trial

INTRODUCTION: Boceprevir was not previously studied with peginterferon alfa-2a/ribavirin in phase III trials in treatment-naïve chronic hepatitis C patients. The international phase IIIb/IV TriCo study was, therefore, designed to evaluate boceprevir in combination with peginterferon alfa-2a/ribaviri...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Infect Dis Ther
Asıl Yazarlar: Ferenci, Peter, Caruntu, Florin A., Lengyel, Gabriella, Messinger, Diethelm, Bakalos, Georgios, Flisiak, Robert
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer Healthcare 2016
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4929089/
https://ncbi.nlm.nih.gov/pubmed/27228998
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40121-016-0110-5
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller